SequelSEC

U S PHYSICAL THERAPY INC /NV USPH

Services-Health Services · CIK 0000885978 · Fiscal year ends 1231

Revenue
$780.99M
Fiscal year ended 2025-12-31
Operating income
$86.68M
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

U S PHYSICAL THERAPY INC /NV (USPH) reported revenue of $780.99M and net income of $39.58M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from U S PHYSICAL THERAPY INC /NV’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.

Income

U S PHYSICAL THERAPY INC /NV income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$780.99M$671.34M$604.80M$553.14M$495.02M$422.97M$481.97M$453.91M$414.05M$356.55M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profit$149.69M$123.92M$121.51M$112.02M$117.18M$94.45M$112.47M$101.66M$90.62M$82.01M
Operating income$86.68M$62.99M$50.51M$56.80M$70.65M$52.41M$67.42M$60.31M$54.73M$49.53M
Net income$39.58M$31.42M$28.24M$32.16M$40.83M$35.19M$40.04M$34.87M$22.26M$20.55M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 15.18Mshares 15.06Mshares 14.19Mshares 12.98Mshares 12.90Mshares 12.84Mshares 12.76MUnavailableUnavailableshares 12.50M
Pretax income$77.81M$60.21M$49.38M$55.57M$73.20M$65.51M$70.91M$60.21M$33.76M$38.15M
Income tax expense$19.81M$14.61M$12.16M$12.16M$15.27M$13.02M$13.65M$11.37M$6.03M$11.88M
Diluted EPS$1.42$1.84$1.28$2.25$2.41$2.48$2.45UnavailableUnavailableUnavailable
Selling, general & administrative$69.26M$58.29M$51.95M$46.11M$46.53M$42.04M$45.05M$41.35M$35.89M$32.48M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

U S PHYSICAL THERAPY INC /NV balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$35.57M$41.36M$152.82M$31.59M$28.57M$32.92M$23.55M$23.37M$21.93M$20.05M
Total assets$1.20B$1.17B$997.24M$858.15M$749.43M$594.36M$630.50M$443.17M$418.98M$351.23M
Current assets$139.99M$137.58M$233.38M$111.27M$95.17M$87.64M$85.39M$79.21M$77.08M$65.96M
Total liabilities$433.81M$408.42M$345.00M$373.59M$296.98M$184.39M$181.39M$92.35M$110.34M$162.54M
Current liabilities$139.04M$116.28M$102.18M$85.49M$83.48M$93.49M$60.56M$41.95M$39.55M$24.62M
Total equity incl. NCI$476.89M$490.02M$477.41M$317.05M$297.18M$277.63M$241.70M$216.88M$206.07M$188.69M
Temporary (mezzanine) equity$293.31M$269.02M$174.83M$167.52M$155.26M$132.34M$137.75M$133.94M$102.57M$0
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$64.25M$59.04M$51.80M$51.90M$46.27M$41.91M$46.23M$44.75M$44.71M$38.84M
Goodwill$692.39M$667.15M$509.57M$494.10M$434.68M$345.65M$317.68M$293.52M$271.34M$226.81M
Long-term debt$152.59M$142.53M$138.99M$175.83M$117.59M$16.60M$50.36M$38.40M$56.73M$50.60M
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

U S PHYSICAL THERAPY INC /NV cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow$75.06M$74.94M$81.98M$58.54M$76.41M$100.00M$62.45M$73.00M$56.53M$51.05M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$36.71M-$149.45M-$45.02M-$81.27M-$124.14M-$51.20M-$37.99M-$23.91M-$43.58M-$32.49M
Financing cash flow-$44.14M-$36.95M$84.27M$25.76M$43.38M-$39.42M-$24.28M-$47.66M-$11.06M-$14.29M
Net change in cash-$5.79M-$111.46M$121.23M$3.03M-$4.35M$9.37M$180.00K$1.44M$1.89M$4.27M
Stock-based compensation$8.27M$7.82M$7.24M$7.26M$7.87M$7.92M$6.98M$5.94M$5.03M$4.96M
Common dividends paid$27.36M$26.54M$24.13M$21.32M$18.76M$4.11M$14.56M$11.66M$10.07M$8.51M
Common share repurchases$5.57M$0$0UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$22.39M$18.68M$15.70M$14.74M$11.59M$10.53M$10.10M$9.76M$9.71M$8.78M

Derived

U S PHYSICAL THERAPY INC /NV derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin19.2%18.5%20.1%20.3%23.7%22.3%23.3%22.4%21.9%23.0%
Operating margin11.1%9.4%8.4%10.3%14.3%12.4%14.0%13.3%13.2%13.9%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue1.1%1.2%1.2%1.3%1.6%1.9%1.4%1.3%1.2%1.4%
Current ratio1.01x1.18x2.28x1.30x1.14x0.94x1.41x1.89x1.95x2.68x
Revenue YoY growth16.3%11.0%9.3%11.7%17.0%-12.2%6.2%9.6%16.1%Unavailable
Net margin5.1%4.7%4.7%5.8%8.2%8.3%8.3%7.7%5.4%5.8%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equity0.32xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate25.5%24.3%24.6%21.9%20.9%19.9%19.2%18.9%17.9%31.1%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open USPH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-09View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2019-12-31

Difference 69656000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.